BTF3 and prostate carcinoma: We found that the anti-BTF3 antibody, but not the isotype IgG, efficiently retrieved the proximal region of each specific RFC promoter in both 293 T and prostate cancer cells (PC-3 and DU145) (Fig. 4f, g).